Drugs / INS37217
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00210015 | Dec 2002 → Apr 2003 | perennial allergic rhinitis | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | INS37217 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00210015 ↗ |
| Route | Intranasal | “INS37217 Nasal Spray” NCT00210015 ↗ |